Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Need for Serious Support for Basic Medical Science in Iran Publisher



Akhondzadeh S1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Psychiatric Research Center, Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, Tehran, Iran

Source: Avicenna Journal of Medical Biotechnology Published:2024


Abstract

[No abstract available]
Related Docs
View other Related Docs
1. Pentoxifylline Adjunct to Risperidone for Negative Symptoms of Stable Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial, International Journal of Neuropsychopharmacology (2025)
2. The Requisiteness for Not Sacrificing Medical Biotechnology in the Coronavirus Era, Avicenna Journal of Medical Biotechnology (2021)
3. The Role of Biotechnology in Latest Therapeutic Approaches for Diabetes Mellitus, Avicenna Journal of Medical Biotechnology (2024)
4. Efficacy and Safety of Sulforaphane for Treatment of Mild to Moderate Depression in Patients With History of Cardiac Interventions: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Psychiatry and Clinical Neurosciences (2021)
5. Novel Osteoporosis Therapeutic Targets Derived From Medical Biotechnology, Avicenna Journal of Medical Biotechnology (2024)
6. Herbal Medicine in the Treatment of Schizophrenia: A Review, Journal of Medicinal Plants (2018)
7. Palmitoylethanolamide As Adjunctive Therapy for Autism: Efficacy and Safety Results From a Randomized Controlled Trial, Journal of Psychiatric Research (2018)
8. L-Carnosine As an Add-On to Risperidone for Treatment of Negative Symptoms in Patients With Stable Schizophrenia: A Double-Blind, Randomized Placebo-Controlled Trial, Psychiatry Research (2018)
Experts (# of related papers)
View all Related Experts
Shahin Akhondzadeh Basti (23)
Ladan Kashani (3)
Other Related Docs
9. Integrating Psychiatry and Medical Biotechnology As a Way to Achieve Scientific, Precision, and Personalized Psychiatry, Avicenna Journal of Medical Biotechnology (2021)
10. Duloxetine Add-On to Risperidone for Treatment of Negative Symptoms in Patients With Stable Schizophrenia: Randomized Double-Blind Placebo-Controlled Study, Pharmacopsychiatry (2016)
11. Efficacy and Safety of Adjunctive Therapy With Fingolimod in Patients With Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Schizophrenia Research (2023)
12. Efficacy and Safety of Pentoxifylline Combination Therapy in Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial, International Clinical Psychopharmacology (2021)
13. Herbal Medicine in the Treatment of Primary Dysmenorrhea, Journal of Medicinal Plants (2015)
14. L-Carnosine As Adjunctive Therapy in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Journal of Child and Adolescent Psychopharmacology (2018)
15. Medical Biotechnology in the Service of Coronavirus Vaccine Discovery and Production, Avicenna Journal of Medical Biotechnology (2021)
16. L -Carnitine Adjunct to Risperidone for Treatment of Autism Spectrum Disorder-Associated Behaviors: A Randomized, Double-Blind Clinical Trial, International Clinical Psychopharmacology (2024)
17. Evidence Based Medicine and Herbal Medicine, Journal of Medicinal Plants (2016)
18. Basic Science and Clinical Studies on Non-Covid-19 Topics, of Coronavirus Victims, Avicenna Journal of Medical Biotechnology (2020)
19. Microbiome and Schizophrenia, Avicenna Journal of Medical Biotechnology (2019)
20. Palmitoylethanolamide As Adjunctive Therapy in Major Depressive Disorder: A Double-Blind, Randomized and Placebo-Controlled Trial, Journal of Affective Disorders (2018)
21. The Trace of Evidence Based Medicine in Avicenna's Approaches, Journal of Medicinal Plants (2016)
22. Herbal Medicine for Women's Health, Journal of Medicinal Plants (2015)
23. Efficacy and Safety of Adjunctive Therapy With Lumateperone in Major Depressive Disorder: A Randomized-, Double-Blind, Placebo-Controlled Clinical Trial, International Clinical Psychopharmacology (2025)